A Response to Sher et al, “Cost-effectiveness Analysis of SBRT Versus IMRT for Low-risk Prostate Cancer” (original) (raw)

Academia.edu no longer supports Internet Explorer.

To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.